Zumutor Biologics

Onward and forward! Zumutor gets a PIND approval for ZM008, marches firmly towards the next regulatory milestone! yourstory.com/2022/07/zumuto…

ZM008 one step closer to clinic linkedin.com/posts/zumutor_…

Funding Alert! We have raised a series A4 round of $6.2Mil$! This will propel further development to IND and First in human! @accelindia @bharat_fund siana capital m.economictimes.com/tech/funding/z…

Our Director @sunitmaity will speak about Biosimilar and Novel Biologics, in this virtual Symposium

Do join the Webinar when our CEO Ms kavitha Iyer Rodrigues discusses her experience and challenges in setting up to scaling business in Healthcare Sector Registration Link: bit.ly/3hDjwkI #BharatInnovationFund #IlluminaForStartups

Association of Biotechnology-Led Enterprises (ABLE) @able_indiabio has constituted a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021. biovoicenews.com/g-s-krishnan-t…

Excited to share a feature in this edition of Biospectrum that has Zumutor’s CEO-Kavitha Iyer Rodrigues bag the entrepreneur of the year 2020 award! This is a validation of consistent work @ Zumutor. #Immunology #noveltherapeutics #zumutor

Listen from our CEO @IyerRodrigues when she speaks about her amazing journey at CII Startathon 2020 #startathon

Biotechnology landscape in India as published in public domain where #Zumutor is mentioned. Data accuracy has not been validated but useful information. youtu.be/_ovJYtcFefg

Another feather in Zumutor’s cap - our Founder- CEO, Kavitha Iyer Rodrigues was awarded the “ Woman Entrepreneur of the year 2020 “ in SMART Bio Awards Category by the Dept of IT/ BT and S&T, Govt of Karnataka @drashwathcn @itbtgok @kbitsMd @ktech_bfc @Startup_Kar @IyerRodrigues

Watch our CEO Ms Kavitha Iyer Rodrigues @IyerRodrigues has to say about Bengaluru tech Summit @blrtechsummit

We have received the grant from #USISTEF for Covid therapeutics development. It's a collaborative project in partnership with Prof Shiladitya Sengupta #COVID19 #antibodylibrary zumutor.com/2020/09/zumuto…

Are you looking for a new Antibody sequence? Please check our INABLRS antibody discovery platform zumutor.com/2020/08/inablr…

@kiranshaw Take care and get well soon

I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way.

We are excited to share that Zumutor Biologics in partnership with Prof Shiladitya Sengupta of Harvard Med has been shortlisted by USIST Endowment Board for development of monoclonal antibody therapeutics for COVID 19. #COVID19 #therapeutics

We're excited of being considered as a key player in the Global Next-Generation Bio-Therapeutic Market study conducted by @DBMROfficial. #novel_biologics #immuno_oncology go.ciie.co/338JLZL

A strategic departure from the biotech incubator requires the coordination....listen it from our CEO Ms. Kavitha Iyer Rodrigues #Zumutor

The pandemic has imposed severe constraints not only on R&D but also on interactions with our SAB. A big thanks to SAB members for making the connect today - the whole board. We hope to get ZM008 develpment on track for IND submission and Phase 1 trials. #immuno_oncolgy #mAb